> top > docs > PMC:7275193 > spans > 7469-8049 > annotations

PMC:7275193 / 7469-8049 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T103 8-15 CL:0000763 denotes myeloid
T104 19-30 CL:0000763 denotes myelogenous
T105 51-69 CL:0000763 denotes myeloproliferative
T106 116-128 GO:0065007 denotes dysregulated
T107 129-142 GO:0048468 denotes production of
T108 150-163 CL:0000763 denotes myeloid cells
T109 172-184 CL:0000094 denotes granulocytes
T110 318-322 PR:000003582 denotes ABL1
T111 329-333 SO:0000704 denotes gene
T112 351-355 PR:000003582 denotes ABL1
T113 485-495 CHEBI:38637;CHEBI:38637 denotes inhibitors
T114 511-520 CHEBI:5291;CHEBI:5291 denotes dasatinib
T115 522-531 CHEBI:17154;CHEBI:17154 denotes nilotinib
T116 537-546 CHEBI:39112;CHEBI:39112 denotes bosutinib
T92873 8-15 CL:0000763 denotes myeloid
T80530 19-30 CL:0000763 denotes myelogenous
T86107 51-69 CL:0000763 denotes myeloproliferative
T56738 116-128 GO:0065007 denotes dysregulated
T82747 129-142 GO:0048468 denotes production of
T78109 150-163 CL:0000763 denotes myeloid cells
T29288 172-184 CL:0000094 denotes granulocytes
T73235 318-322 PR:000003582 denotes ABL1
T551 329-333 SO:0000704 denotes gene
T43325 351-355 PR:000003582 denotes ABL1
T25827 485-495 CHEBI:38637;CHEBI:38637 denotes inhibitors
T2859 511-520 CHEBI:5291;CHEBI:5291 denotes dasatinib
T30323 522-531 CHEBI:17154;CHEBI:17154 denotes nilotinib
T65535 537-546 CHEBI:39112;CHEBI:39112 denotes bosutinib

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T31 150-163 Body_part denotes myeloid cells http://purl.org/sig/ont/fma/fma70339
T32 158-163 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T33 172-184 Body_part denotes granulocytes http://purl.org/sig/ont/fma/fma62854
T34 220-231 Body_part denotes chromosomal http://purl.org/sig/ont/fma/fma67093
T35 283-293 Body_part denotes chromosome http://purl.org/sig/ont/fma/fma67093
T36 329-333 Body_part denotes gene http://purl.org/sig/ont/fma/fma74402
T37 363-370 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T38 385-393 Body_part denotes tyrosine http://purl.org/sig/ont/fma/fma82768
T39 469-477 Body_part denotes Tyrosine http://purl.org/sig/ont/fma/fma82768

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T41 31-39 Phenotype denotes leukemia http://purl.obolibrary.org/obo/HP_0001909
T42 70-78 Phenotype denotes neoplasm http://purl.obolibrary.org/obo/HP_0002664

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T79 19-39 Disease denotes myelogenous leukemia http://purl.obolibrary.org/obo/MONDO_0004643
T80 31-39 Disease denotes leukemia http://purl.obolibrary.org/obo/MONDO_0005059
T81 41-44 Disease denotes CML http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996
T83 51-78 Disease denotes myeloproliferative neoplasm http://purl.obolibrary.org/obo/MONDO_0020076
T84 70-78 Disease denotes neoplasm http://purl.obolibrary.org/obo/MONDO_0005070|http://purl.obolibrary.org/obo/MONDO_0021079

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T103 49-50 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T104 158-163 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T105 252-254 http://purl.obolibrary.org/obo/CLO_0050507 denotes 22
T106 329-333 http://purl.obolibrary.org/obo/OGG_0000000002 denotes gene
T107 401-409 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T108 418-421 http://purl.obolibrary.org/obo/CLO_0051582 denotes has

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T49 363-370 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T50 385-393 Chemical denotes tyrosine http://purl.obolibrary.org/obo/CHEBI_18186
T51 469-495 Chemical denotes Tyrosine kinase inhibitors http://purl.obolibrary.org/obo/CHEBI_38637
T52 469-477 Chemical denotes Tyrosine http://purl.obolibrary.org/obo/CHEBI_17895|http://purl.obolibrary.org/obo/CHEBI_18186
T54 485-495 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T55 511-520 Chemical denotes dasatinib http://purl.obolibrary.org/obo/CHEBI_49375|http://purl.obolibrary.org/obo/CHEBI_70839
T57 522-531 Chemical denotes nilotinib http://purl.obolibrary.org/obo/CHEBI_52172
T58 537-546 Chemical denotes bosutinib http://purl.obolibrary.org/obo/CHEBI_39112

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T4 394-409 http://purl.obolibrary.org/obo/GO_0016301 denotes kinase activity
T5 478-495 http://purl.obolibrary.org/obo/GO_0033673 denotes kinase inhibitors

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T68 0-185 Sentence denotes Chronic myeloid or myelogenous leukemia (CML) is a myeloproliferative neoplasm which is defined as uncontrolled and dysregulated production of mature myeloid cells, mainly granulocytes.
T69 186-414 Sentence denotes It results from acquired abnormal chromosomal translocation, t(9; 22), known as the Philadelphia chromosome, which contains the BCR-ABL1 fused gene and produces BCR-ABL1 fusion protein with abnormal tyrosine kinase activity [6].
T70 415-468 Sentence denotes It has three phases: chronic, accelerated, and blast.
T71 469-580 Sentence denotes Tyrosine kinase inhibitors (TKIs) such as dasatinib, nilotinib, and bosutinib are the first-line treatment [7].

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
212 318-322 Gene denotes ABL1 Gene:25
213 351-355 Gene denotes ABL1 Gene:25
214 511-520 Chemical denotes dasatinib MESH:D000069439
215 522-531 Chemical denotes nilotinib MESH:C498826
216 537-546 Chemical denotes bosutinib MESH:C471992
217 0-39 Disease denotes Chronic myeloid or myelogenous leukemia MESH:D015464
218 41-44 Disease denotes CML MESH:D015464
219 70-78 Disease denotes neoplasm MESH:D009369